Analyst Price Target is $98.11
▲ +42.05% Upside Potential
This price target is based on 9 analysts offering 12 month price targets for Encompass Health in the last 3 months. The average price target is $98.11, with a high forecast of $110.00 and a low forecast of $88.00. The average price target represents a 42.05% upside from the last price of $69.07.
Current Consensus is
The current consensus among 9 investment analysts is to buy stock in Encompass Health. This Buy consensus rating has held steady for over two years.
Encompass Health Corp. engages in the provision of post-acute healthcare services. It operates through the Inpatient Rehabilitation and Home Health and Hospice segments. The Inpatient Rehabilitation segment operates inpatient rehabilitation hospitals that provides rehabilitative treatment and care to patients who are recovering from stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions and amputations. The Home Health and Hospice segment provides Medicare-certified home nursing, specialized home care and in-home services. The company was founded by Richard M. Scrushy on February 22, 1984 and is headquartered in Birmingham, AL.